169 Results (Page 6 of 7)
Mexico Markets Research Reports
Mexico Dental Fluoride Treatment Market Analysis
The Mexico Dental Fluoride Treatment Market was valued at $227.5 Mn in 2023 and is projected to grow at a CAGR of 4.15% from 2023 to 2023, to $302.4 Mn by 2030. The key drivers of this industry are growing prevalence of dental caries coupled with increasing awareness regarding oral health and hygiene, increasing the intake of sugary drinks and food, projected to drive the market. The industry is primarily dominated by players such as Grupo Grisi, Laboratories Azteca, Colgate, Philips, Dentsply Sirona, VOCO, DÜRRDENTAL among others.
Mexico Hemodialysis Equipment Market Analysis
The Mexico Hemodialysis Equipment Market was valued at $211.8 Mn in 2023 and is projected to grow at a CAGR of 7.85% from 2023 to 2023, to $359.5 Mn by 2030. The key drivers of this industry are increasing incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), availability of advanced dialysis machines and consumables, government initiatives to improve dialysis accessibility, growing adoption of home haemodialysis, expansion of dialysis service providers which has contributed to market growth. The industry is primarily dominated by players such as Stryker, Boston Scientific Corporation, Baxter, B. Braun SE, Fresenius Medical Care AG, Medtronic among others.
Mexico Financial Assistance Programs Market Analysis
The Mexico Financial Assistance Programs Market was valued at $425.1 Mn in 2023 and is projected to grow at a CAGR of 14.85% from 2023 to 2023, to $1,120.5 Mn by 2030. The market is driven by various sector such as rising drug cost, complex insurance landscape, regulatory environment, market competition, patient adherence concern etc. The prominent pharmaceutical companies providing financial assistance to patient are such as Sanofi, AstraZeneca, AbbVie, Merck, GSK, Johnson & Johnson, Novartis among others.
Mexico Periodontal Therapeutics Market Analysis
The Mexico Periodontal Therapeutics Market was valued at $13.1 Mn in 2023 and is predicted to grow at a CAGR of 7.45% from 2023 to 2030, to $21.6 Mn by 2030. Mexico Periodontal Therapeutics Market is growing due to Prevalence of periodontitis, Emphasis on Preventive Oral Care, and Shift Towards Minimally Invasive Treatments. The market is primarily dominated by players such as Pfizer Inc., Lupin Ltd, Teva Pharmaceuticals USA, Sun Pharmaceutical Industries Ltd, Tokyo Chemical Industry Co. Ltd., and Bausch Health Companies Inc.
Mexico Cold Pain Therapy Market Analysis
The Mexico Cold Pain Therapy Market was valued at $33 Mn in 2022 and is predicted to grow at a CAGR of 5.45% from 2023 to 2030, to $50 Mn by 2030. The key drivers of this industry include the rising burden of pain disorders, expanding product offerings, and growing public awareness. The industry is primarily dominated by players such as DJO Global, Hisamitsu, Medichill, Ossur, Brownmed, Pfizer, and Unexo among others.
Mexico Radiology Service Market Analysis
The Mexico Radiology Service Market was valued at $60 Mn in 2023 and is predicted to grow at a CAGR of 14.95% from 2023 to 2030, to $159.1 Mn by 2030. The key drivers of the market include increasing burden of cancer, aging population, and emphasis on preventative care. The prominent players of the Mexico Radiology Service Market are Hospital Guadalajara, Hospital Angeles, Hospital Americano, Hospiten International Hospital Group, and Médica Sur, among others.
Mexico Biobanks Market Analysis
The Mexico Biobanks Market was valued at $1,151.10 Mn in 2023 and is predicted to grow at a CAGR of 9.05% from 2023 to 2030, to $2,111.02 Mn by 2030. The key drivers of this industry include the prevalence of diseases, advancements in genomic research, and government and institutional support. The industry is primarily dominated by players such as Merck KGaA, Thermo Fisher Scientific, QIAGEN, and Avantor among others.
Mexico MRI Market Analysis
The Mexico MRI Market was valued at $99.60 Mn in 2023 and is predicted to grow at a CAGR of 6.75% from 2023 to 2030, to $157.34 Mn by 2030. The key drivers of this industry include increasing prevalence of chronic diseases, medical tourism, and supportive government initiatives. The key players in the industry are Siemens Healthineers, Esaote, K.A. Imaging, and Fonar Corporation among others.
Mexico Hypersomnia Therapeutics Market Analysis
The Mexico Hypersomnia Therapeutics Market was valued at $13.80 Mn in 2023 and is predicted to grow at a CAGR of 4.5% from 2023 to 2030, to $18.78 Mn by 2030. The key drivers of this industry include the rising prevalence of sleep disorders, expanding geriatric population, early detection, and advancement in diagnostic tools. The key players in the industry are Sanofi, Pfizer, Merck, and Laboratorios Sanfer among others.
Mexico Dental Implant Market Analysis
Mexico Dental Implant Market was valued at $74.80 Mn in 2023 and is predicted to grow at a CAGR of 10.05% from 2023 to 2030, to $146.30 Mn by 2030. The key drivers of this industry include growing demand for aesthetics, growing dental awareness, medical tourism potential, and improved dental infrastructure. The industry is primarily dominated by Straumann Group, Dentsply Sirona, Zimmer Biomet Ltd, and Henry Schein Holdings Ltd among others.
Mexico Conjunctivitis Therapeutics Market Analysis
The Mexico Conjunctivitis Therapeutics Market was valued at $62 Mn in 2022 and is predicted to grow at a CAGR of 5.65% from 2023 to 2030, to $95 Mn by 2030. The key drivers of this industry include the increasing incidence of conjunctivitis, growing demand for eye care, and pharmaceutical innovation in the industry. The industry is primarily dominated by players such as Novartis, Pfizer, Bausch & Lomb, Sanofi, Santen, Allergan, and AbbVie among others.
Mexico PET Scan Market Analysis
The Mexico PET Scan Market was valued at $29.1 Mn in 2023 and is predicted to grow at a CAGR of 5.65% from 2023 to 2030, to $42.8 Mn by 2030. The key drivers of the market include increased healthcare expenditure, increased geriatric population, and rising prevalence of chronic diseases. The prominent players of the Mexico PET Scan Market are GE Healthcare, Hitachi, Siemens Healthineers, Toshiba, and Canon Medical Systems, among others.
Mexico Genomic Diagnostics Market Analysis
Mexico Genomic Diagnostics Market was valued at $489.75 Mn in 2023 and is predicted to grow at a CAGR of 16.75% from 2023 to 2030, to $1,448.01 Mn by 2030. The key drivers of this industry include increasing demand for personalized medicine, government initiatives, and technological advancements. The industry is primarily dominated by Illumina, 23andMe, Myriad Genetics, and Amgen among others.
Mexico Mouth Ulcer Therapeutics Market Analysis
The Mexico Mouth Ulcer Therapeutics Market was valued at $22.8 Mn in 2023 and is projected to grow at a CAGR of 4.15% from 2023 to 2023, to $30.3 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players such as Sanofi, Bayer, Pfizer, Genomma Lab International, Liomont among others.
Mexico Bio-implant Market Analysis
The Mexico Bio-implant Market was valued at $975 Mn in 2023 and is predicted to grow at a CAGR of 6.15% from 2023 to 2030, to $1480.6 Mn by 2030. The Mexico Bio-implant Market is growing due to Demographic Trends, Healthcare Expenditure, and Medical Tourism. The market is primarily dominated by players such as Medtronic Mexico, Zimmer Biomet Mexico, Stryker Mexico, DePuy Synthes Mexico, Boston Scientific Corporation, and Johnson & Johnson Services.
Mexico Compression Therapy Market Analysis
Mexico Compression Therapy Market was valued at $57 Mn in 2022 and is estimated to reach $90 Mn in 2030, exhibiting a CAGR of 5.85% during the forecast period. The rise in the prevalence of venous ailments like leg ulcers, deep vein thrombosis, lymphedema, varicose veins, and blood clots plays a significant role in the growth of the compression therapy market. Key players in this industry comprise Sigvaris, Medi, Juzo, Jobst, Bauerfeind, Lympha Press, DJO Global, FLA Orthopedics, Al-Medical, and Eurofarma.
Mexico Bariatric Surgery Devices Market Analysis
The Mexico Bariatric Surgery Devices Market was valued at $39.9 Mn in 2023 and is projected to grow at a CAGR of 5.45% from 2023 to 2023, to $57.9 Mn by 2030. Major factors driving the market for bariatric surgical devices include the rising incidence of adult obesity brought on by altered lifestyle patterns and excessive calorie consumption. The demand for bariatric operations is also anticipated to rise over the forecast period due to increased government backing and growing public awareness of the market's unhealthy food and beverage offerings and how they affect BMI, thus driving the market growth of the Bariatric Surgery Devices. The prominent players in the market are Bhio Supply, Medicone, Scitech Medical, Medtronic, B. Braun, Johnson & Johnson, Cousin Surgery among others.
Mexico CT Scan Market Analysis
Mexico CT Scan Market was valued at $69.15 Mn in 2023 and is predicted to grow at a CAGR of 8.12% from 2023 to 2030, to $119.44 Mn by 2030. The key drivers of this industry include the rising burden of chronic diseases, expanding healthcare infrastructure, and the aging population. The industry is primarily dominated by GE HealthCare, Siemens Healthineers, Canon Medical Systems, and NeuroLogica Corp. among others.
Mexico Lipid Disorder Therapeutics Market Analysis
The Mexico Lipid Disorder Therapeutics Market was valued at $60.6 Mn in 2023 and is predicted to grow at a CAGR of 12.63% from 2023 to 2030, to $139.3 Mn by 2030. Mexico Lipid Disorder Therapeutics Market is growing due to Growing Awareness and Diagnosis Rates, Collaborations, Partnerships, and Increasing Healthcare Expenditure. The industry is primarily dominated by players such as Sanofi, Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., AbbVie Inc., Viatris, AstraZeneca PLC, and Dr. Reddys Laboratories Ltd.
Mexico Mental Health Apps Market Analysis
The Mexico Mental Health Apps Market was valued at $93 Mn in 2023 and is predicted to grow at a CAGR of 15.45% from 2023 to 2030, to $254.24 Mn by 2030. The key drivers of this industry include rising awareness, increasing smartphone penetration, and reduced stigma. The industry is primarily dominated by players such as Headspace, Calm, Happify, and Yana among others.
Mexico Cough Hypersensitivity Syndrome Therapeutics Market Analysis
The Mexico Cough Hypersensitivity Syndrome Therapeutics Market was valued at $122 Mn in 2022 and is predicted to grow at a CAGR of 6.15% from 2023 to 2030, to $196 Mn by 2030. The main factors driving this industry include the increasing prevalence of Cough Hypersensitivity Syndrome, expanding healthcare infrastructure, and the development of advanced therapeutics. The industry is primarily dominated by players such as Roche, Pfizer, Teva, Novartis, Johnson & Johnson, and GSK among others.
Mexico Herbal Supplements Market Report
The Mexico Herbal Supplements Market was valued at $78.90 Mn in 2023 and is predicted to grow at a CAGR of 6.45% from 2023 to 2030, to $122.21 Mn by 2030. The key drivers of this industry include an aging population, growing health consciousness, and preference for personalized supplements. The industry is primarily dominated by players such as Himalaya Wellness, Herbalife, Amway, and NOW Foods among others.
Mexico Actinic Keratosis Therapeutic Market Analysis
Mexico Actinic Keratosis Therapeutic Market is expected to expand at a CAGR of 5.15% from $102 Mn in 2022 to $152 Mn by 2030. Rising prevalence paired with certain environmental factors, changing economic landscape, disposable incomes and increasing access to healthcare services in Mexico are assumed to contribute to the market's expansion. International and local players LEO Pharma, Bausch Health, Almirall, 3M, Cipher Pharmaceuticals, and Lumenis etc contribute with cryotherapy and light therapy devices used for the therapeutic management of Actinic Keratosis
Mexico Constipation Therapeutics Market Analysis
Mexico Constipation Therapeutics Market was valued at $273 Mn in 2022 and is estimated to reach $460 Mn in 2030, exhibiting a CAGR of 6.75% during the forecast period. The constipation therapeutics market is experiencing growth driven by rising global rates of constipation associated with factors like aging, sedentary lifestyles, and poor dietary habits, as well as the expanding elderly population, which is particularly prone to chronic conditions. Notable participants in this industry include AbbVie, Allergan, Boehringer Ingelheim, EMS, Farmoquímica, Grünenthal, Johnson & Johnson, Norgine, Pfizer, and Sanofi.
Mexico Brain Cancer Therapeutics Market
Mexico Brain Cancer Therapeutics Market valued at $35 Mn in 2022, projected to reach $79 Mn by 2030 with a 10.85% CAGR. The demand for brain cancer therapeutics is projected to be fuelled by the expected increase in the occurrence of brain cancer, particularly glioblastoma multiforme. This surge in demand for therapeutic interventions is likely to shape the market landscape. Notable participants in the pharmaceutical sector include Pfizer, AstraZeneca, Merck & Co., Siemens, Carestream Health, Eisai Co., Genentech, Bristol-Myers Squibb, Eli Lilly, and Sanofi.